Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
about
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyKASL clinical practice guidelines: management of hepatitis CChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.Chronic hepatitis C and liver fibrosis.Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Non-invasive diagnosis of liver fibrosis in chronic hepatitis CHepatitis C virus infection influences the S-methadone metabolite plasma concentrationNew noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.Risk prediction models for hepatocellular carcinoma in different populations.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver diseaseLiver enzyme alteration: a guide for clinicians.Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis BSimple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.Effect of WeiJia on carbon tetrachloride induced chronic liver injuryA comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progressionA review on laboratory liver function tests.A practical approach to managing patients with HCV infection.Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infectionLecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients.RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B.Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinomaNon-invasive serum fibrosis markers: A study in chronic hepatitis.Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.Evaluation of liver fibrosis: a concise review.The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessmentNoninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parametersDiagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study.Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.Advanced hepatocellular carcinoma: which staging systems best predict prognosis?Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.
P2860
Q24680285-F2866E89-51F8-4E24-98B7-D57E73DDBE13Q26752471-0956D76E-FE4A-47DE-B02D-5ED1204D89B3Q26773289-445DBBC4-E1E3-4876-BAC6-38E5D4819820Q26777511-92496683-05DE-4636-84E7-ACC07CCC079AQ26779866-DAD74122-F133-4866-8621-35A663F978CBQ26825671-0811768C-4287-4842-9777-29690EDD5055Q26853160-A9A8F801-81F3-41D0-AA47-597FE421CB11Q26865956-1071F4E8-4BBC-4270-9CC7-3235E061FA5EQ28534782-DDC9555D-7DD2-462F-B189-7D19AC829882Q30354346-6C31DB5D-ABE5-4F66-A9D8-D36DEB3F529EQ30383460-09DC849D-95AB-43FE-BCC2-264FA82FF7C3Q30476922-1E783E6B-4266-4B90-89C0-BF259738BFCDQ33421239-A0E29B02-4CF3-4681-BA01-0C9C5A2B75AFQ33565557-B99864D8-A343-4D86-951F-6C59FBFB2EFBQ33759637-943518E9-A026-4AE0-A542-55AF16FDB7A8Q33787916-23E27FAB-A03E-4D15-9C15-CFD16F52B638Q33855796-53C86067-1416-4F95-870E-BEC997DABAEDQ33866383-51AFFCC9-C6AB-481B-90F0-7499653035AEQ33866594-6307C863-E623-4AA7-A38E-A0073FC998F5Q33877980-C259746E-5992-4774-8E15-E8783ABE6C01Q34088623-1BBFA309-E3FD-45C6-A1B8-A80C4F516BD0Q34207037-1E3149F4-625D-436A-8EE7-A4FA515B7726Q34321014-5B002F35-AC2F-40FD-8A82-0C2B6A6870B6Q34485082-DD9C8B96-3CBB-43DF-B35E-35DE2BF0790CQ34684406-AF64E89C-82E8-456D-9399-2BF3280970F8Q34746864-76F02EC3-BA74-47C4-9E87-E1FDD78923D7Q34769512-43B7F176-CC34-447B-8723-264BB10814C0Q34851047-0AAA6213-4D80-49D3-8318-D2A7821360DCQ35364559-73792BE7-8D1E-4395-8F48-1E79CDCE82B3Q35458645-407725B3-82BA-4C15-ACB5-47EFF4DCDD65Q35573240-A8731DB3-F92F-4229-A3F7-4492D364E4AEQ35794328-A8317BDA-AE60-4BE7-8472-7399AE98E3A4Q35992231-5ED767E3-1807-4187-B59B-A25731928592Q36049926-CB503192-9773-41DE-AAFF-F9E448D17B32Q36308905-B5CC2BBC-AC3A-4B05-B8D3-74A6B4B41C76Q36402864-1873848B-CD55-433B-8991-D5E903D463B7Q36824936-C3BBE2B1-C2C6-4428-959D-C75D18B39C40Q36836103-182E3832-16F1-43D4-91CE-752CBAA82506Q36914350-10F9EA67-6220-411D-9F40-CFC16AD29DF7Q36922243-B7C4B0B1-4A41-43AF-BE08-57A810BEACD1
P2860
Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Validity and clinical utility ...... related chronic liver disease.
@en
Validity and clinical utility ...... related chronic liver disease.
@nl
type
label
Validity and clinical utility ...... related chronic liver disease.
@en
Validity and clinical utility ...... related chronic liver disease.
@nl
prefLabel
Validity and clinical utility ...... related chronic liver disease.
@en
Validity and clinical utility ...... related chronic liver disease.
@nl
P2093
P1476
Validity and clinical utility ...... related chronic liver disease.
@en
P2093
Alberto Fasoli
Bruno Chiarbonello
Domenico Risso
Emanuela Testa
Federica Botta
Federica Malfatti
Paola Ceppa
Paola Romagnoli
Roberto Testa
P304
P356
10.1001/ARCHINTE.163.2.218
P407
P577
2003-01-01T00:00:00Z